Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

KNTEKNTE
14 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in KINNATE BIOPHARMA INC

DEUTSCHE BANK AG\ previously held 0 shares of KNTE (KINNATE BIOPHARMA INC), worth $0 as of 2024-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$845,000

Total Shares Change

-27,127

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%
0
2024-Q1
Unchanged
114,846
0.0%
$305,4900.0%
0
2023-Q4
Unchanged
114,846
0.0%
$272,1850.0%
0
2023-Q3
Unchanged
114,846
0.0%
$160,7840.0%
0
2023-Q2
Decreased
114,846
-13.6%
$347,9830.0%
0
2023-Q1
Increased
132,880
+1.5%
$830,5000.0%
25
2022-Q4
Increased
130,950
+0.1%
$798,7950.0%
25
2022-Q3
Decreased
130,754
-1.5%
$1.6M0.0%
0
2022-Q2
Increased
132,705
+0.5%
$1.7M0.0%
26
2022-Q1
Decreased
132,038
-1.2%
$1.5M0.0%
0
2021-Q4
Increased
133,696
+0.6%
$2.4M0.0%
26
2021-Q3
Increased
132,866
+5.2%
$3.1M0.0%
28
2021-Q2
Increased
126,311
+365.6%
$2.9M0.0%
42
2021-Q1
New
27,127
-
$845,0000.0%
34

Other major holders of KNTE: RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used